Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma

Table 3 Characteristics of patient samples with hepatocellular carcinoma

No.	Sex	Age (yr)	Disease, etiology	Grade	Stage
c002	M	71	HCC, HBV	I	I
c005	M	42	HCC, HBV	I	I
c025	M	34	HCC, HBV	I	I
c009	M	58	HCC, HBV	I	IIb
c021	M	50	HCC, HBV	I	IIb
c042	M	48	HCC, HBV	I
c045	M	49	HCC, HBV	I
c014	M	48	HCC, HBV	II	I
c046	F	53	HCC, HBV	II
c023	F	34	HCC, HBV	III	IIa
c027	M	45	HCC, HBV	III	IIa
c026	F	18	HCC, HBV	III	IIb
c029	M	43	HCC, HBV	III	IIb
c043	M	61	HCC, HBV	III
c044	M	56	HCC, HBV	III
c020	M	49	HCC, HBV	IV	IIb
c040	M	52	HCC, HBV	IV
c004	M	64	HCC, HBV
c011	M	41	HCC, HBV
c019	F	40	HCC, HBV
c028	M	50	HCC, HBV
c015	M	48	HCC	I	I
c001	M	37	HCC	I	IIa
c003	M	62	HCC	I	IIa
c007	F	65	HCC	III	IIa
c022	M	64	HCC	IV	IIa

HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus.